Literature DB >> 1862747

Tenoxicam concentrations in synovium and joint cartilage in humans.

B Bannwarth1, P Netter, F Lapicque, D Mainard, P Fener, P Gillet, A Gaucher.   

Abstract

Tenoxicam is an NSAID of the oxicam group. Its distribution in articular tissues was investigated in 12 patients who required total arthroplasty of the hip. They were given tenoxicam 20 mg once daily for 8 to 30 days before surgery. Blood, synovium and cartilage samples were taken concurrently during surgery, about 14 hours after the last tenoxicam dose. The tissues were ground using a freeze grinder. Tenoxicam was assayed by HPLC. Tenoxicam concentrations averaged 6.21 +/- 3.81 micrograms/ml in plasma, 7.56 +/- 4.67 micrograms/g in synovium and 2.05 +/- 1.43 micrograms/g in cartilage. The individual synovium/cartilage ratios ranged from 1.9 to 9.7. Finally tenoxicam exhibited more affinity for its target organ (synovial tissue) than for joint cartilage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1862747     DOI: 10.1007/bf01980889

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  Effects of hormones and drugs on cartilage repair.

Authors:  P Franchimont; C Bassleer; Y Henrotin
Journal:  J Rheumatol Suppl       Date:  1989-08

2.  Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio.

Authors:  P H Hinderling; D Hartmann; C Crevoisier; U Moser; P Heizmann
Journal:  Ther Drug Monit       Date:  1988       Impact factor: 3.681

3.  Concentration of azapropazone in synovial tissues and fluid.

Authors:  H Spahn; K Thabe; E Mutschler; K Tillmann; I Gikalov
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Synovial fluid kinetics of non-steroidal anti-inflammatory drugs.

Authors:  D E Furst
Journal:  Agents Actions Suppl       Date:  1985

5.  Diffusion of oxyphenbutazone into synovial fluid, synovial tissue, joint cartilage and cerebrospinal fluid.

Authors:  A Gaucher; P Netter; G Faure; J P Schoeller; A Gerardin
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.

Authors:  W J Wallis; P A Simkin
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

7.  The transsynovial distribution of oxaprozin.

Authors:  M Kurowski; H Thabe
Journal:  Agents Actions       Date:  1989-06

8.  Drug assay in ground tissues: example of ketoprofen diffusion into tonsillar tissue.

Authors:  F Lapicque; R Jankowski; P Netter; B Bannwarth; C Guillemin; M C Bene; C Monot; M Wayoff
Journal:  J Pharm Sci       Date:  1990-09       Impact factor: 3.534

Review 9.  Cartilage metabolism and anti-inflammatory drugs in osteoarthritis.

Authors:  E V Hess; J H Herman
Journal:  Am J Med       Date:  1986-11-28       Impact factor: 4.965

10.  Determination of tenoxicam in human plasma by high-performance liquid chromatography.

Authors:  P Heizmann; J Körner; K Zinapold
Journal:  J Chromatogr       Date:  1986-01-10
  10 in total
  5 in total

Review 1.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Where are peripheral analgesics acting?

Authors:  B Bannwarth; F Demotes-Mainard; T Schaeverbeke; J Dehais
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

3.  The effect of intra-articular Tenoxicam on knee effusion after arthroscopy.

Authors:  Roger Jawish; Hassan Najdi; Claude Abi Safi; Ali Chameseddine
Journal:  Int Orthop       Date:  2015-01-06       Impact factor: 3.075

4.  Comparison of intra-articular tenoxicam and oral tenoxicam for pain and physical functioning in osteoarthritis of the knee.

Authors:  Zeliha Unlu; Kamuran Ay; Cigdem Tuzun
Journal:  Clin Rheumatol       Date:  2005-10-15       Impact factor: 2.980

Review 5.  Clinical pharmacokinetics of tenoxicam.

Authors:  O G Nilsen
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.